GOSS Latest Headlines

Gossamer Bio downgraded by Cantor on unclear regulatory path for seralutinib

at seekingalpha.com (Mon, 23-Mar 3:20 PM)

Bracing for Stagflation? These 2 Stocks Offer Mouth-Watering Upside

at www.tipranks.com (Thu, 19-Mar 7:11 PM)

Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and Silexion Therapeutics (SLXN)

at www.tipranks.com (Thu, 19-Mar 10:50 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS), High Tide (HITI) and Arvinas Holding Company (ARVN)

at www.tipranks.com (Thu, 19-Mar 8:30 AM)

Gossamer Bio’s Seralutinib Future in Doubt After PROSERA Miss in PAH Raises FDA, Funding and Viability Risks

at www.tipranks.com (Thu, 19-Mar 2:00 AM)